201 related articles for article (PubMed ID: 14983032)
21. Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection.
Addo MM; Draenert R; Rathod A; Verrill CL; Davis BT; Gandhi RT; Robbins GK; Basgoz NO; Stone DR; Cohen DE; Johnston MN; Flynn T; Wurcel AG; Rosenberg ES; Altfeld M; Walker BD
PLoS One; 2007 Mar; 2(3):e321. PubMed ID: 17389912
[TBL] [Abstract][Full Text] [Related]
22. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.
Kelleher AD; Carr A; Zaunders J; Cooper DA
J Infect Dis; 1996 Feb; 173(2):321-9. PubMed ID: 8568292
[TBL] [Abstract][Full Text] [Related]
23. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
24. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.
Hua S; Lécuroux C; Sáez-Cirión A; Pancino G; Girault I; Versmisse P; Boufassa F; Taulera O; Sinet M; Lambotte O; Venet A
PLoS One; 2014; 9(7):e101920. PubMed ID: 25000587
[TBL] [Abstract][Full Text] [Related]
25. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):36-9. PubMed ID: 26796651
[TBL] [Abstract][Full Text] [Related]
26. Production of CD8+ T cell nonlytic suppressive factors by CD28, CD38, and HLA-DR subpopulations.
Jiang JQ; Balasubramanian S; Hawley-Foss NC; Badley AD; Rosenthal KL; Copeland KF
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):497-502. PubMed ID: 12882659
[TBL] [Abstract][Full Text] [Related]
27. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
[TBL] [Abstract][Full Text] [Related]
28. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions?
Savarino A; Bottarel F; Malavasi F; Dianzani U
AIDS; 2000 Jun; 14(9):1079-89. PubMed ID: 10894271
[No Abstract] [Full Text] [Related]
29. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Gigase P; Young G; Hannet I; Vanlangendonck F; Hulstaert F; Bach BA
AIDS; 1992 Aug; 6(8):793-7. PubMed ID: 1418775
[TBL] [Abstract][Full Text] [Related]
30. Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical status.
Jiang JD; Schlesinger M; Sacks H; Mildvan D; Roboz JP; Bekesi JG
J Clin Immunol; 1997 Mar; 17(2):185-92. PubMed ID: 9083895
[TBL] [Abstract][Full Text] [Related]
31. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
[TBL] [Abstract][Full Text] [Related]
32. The increased CD38 expressed by lymphocytes infected with HIV-1 is a fully active NADase.
Bofill M; Parkhouse RM
Eur J Immunol; 1999 Nov; 29(11):3583-7. PubMed ID: 10556812
[TBL] [Abstract][Full Text] [Related]
33. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.
Hunt PW; Brenchley J; Sinclair E; McCune JM; Roland M; Page-Shafer K; Hsue P; Emu B; Krone M; Lampiris H; Douek D; Martin JN; Deeks SG
J Infect Dis; 2008 Jan; 197(1):126-33. PubMed ID: 18171295
[TBL] [Abstract][Full Text] [Related]
34. 'Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses.
Lederman MM; Kalish LA; Asmuth D; Fiebig E; Mileno M; Busch MP
AIDS; 2000 May; 14(8):951-8. PubMed ID: 10853976
[TBL] [Abstract][Full Text] [Related]
35. Increased serum and mRNA levels of RANTES associated with elevated levels of activated CD8+CD38+ T cells in HIV-1 infected individuals.
Müller P; Engelstädter M; Werner A; Braner J; Staszewski S; Miller V; Doerr HW; Kurth R; Cichutek K
Intervirology; 1997; 40(4):263-70. PubMed ID: 9612728
[TBL] [Abstract][Full Text] [Related]
36. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
Choremi-Papadopoulou H; Tsalimalma K; Dafni U; Dimitracopoulou A; Kordossis T
J Med Virol; 2004 Jun; 73(2):235-43. PubMed ID: 15122798
[TBL] [Abstract][Full Text] [Related]
37. Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy.
Viganó A; Saresella M; Rusconi S; Ferrante P; Clerici M
Lancet; 1998 Dec; 352(9144):1905-6. PubMed ID: 9863793
[No Abstract] [Full Text] [Related]
38. CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.
Mocroft A; Bofill M; Lipman M; Medina E; Borthwick N; Timms A; Batista L; Winter M; Sabin CA; Johnson M; Lee CA; Phillips A; Janossy G
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):158-62. PubMed ID: 9052725
[TBL] [Abstract][Full Text] [Related]
39. Increases in soluble CD8 antigen in plasma, and CD8+ and CD8+CD38+ cells in human immunodeficiency virus type-1 infection.
Yagi MJ; Chu FN; Jiang JD; Wallace J; Mason P; Liu Y; Carafa J; Bekesi JG
Clin Immunol Immunopathol; 1992 May; 63(2):126-34. PubMed ID: 1611715
[TBL] [Abstract][Full Text] [Related]
40. CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients.
Sherman GG; Scott LE; Galpin JS; Kuhn L; Tiemessen CT; Simmank K; Meddows-Taylor S; Meyers TM
Pediatr Res; 2002 Jun; 51(6):740-5. PubMed ID: 12032270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
